NIH awards $6.9M to advance potential Alzheimer’s disease treatment
NIH awards $6.9M to advance potential Alzheimer’s disease treatment
Researchers at Penn Medicine and UC San Diego will develop a tau-targeting drug candidate through IND-enabling studies, a potential disease-modifying Alzheimer’s treatment for future clinical trials.